Treatment News

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News


February 28, 2014
HIV Treatment Leads to Major Drop in New Infections in BC
British Columbia offers solid, real-world evidence that the HIV treatment as prevention (TasP) strategy is highly effective.
February 27, 2014
Supplements That May Slow HIV Can Fuel Prostate Cancer
High-dose supplementation with selenium and vitamin E can raise the risk of high-grade prostate cancer among certain men.
February 26, 2014
HIV Rate Is Four Times Higher Among Mental Health Patients
People receiving care for mental illness are four times more likely to have HIV than the general population, and many are unaware of their status.
February 25, 2014
Parsing the Variables That Raise HIV Risk Among Black MSM
Various behavioral, health, educational and economic factors are linked to recent HIV infection among black men who have sex with men.
February 24, 2014
Gay Men, IDUs and People With HIV Should Test for Hep B
The U.S. Preventative Services Task Force has proposed that certain high-risk groups, including people with HIV, should be tested for hepatitis B.
February 21, 2014
THC in Pot Affects Monkey SIV; Half-Baked HIV Reports Follow
A study of the effects of a component of marijuana on the disease progression of a simian version of HIV had led to highly inaccurate news reports.
February 19, 2014
Truvada as PrEP Appears Not to Damage Kidneys
The use of Truvada as pre-exposure prophylaxis (PrEP) leads to a very small challenge to kidney function that is reversible after stopping treatment.
A Low CD4 Count Despite Low Viral Load Raises Risk of Death
Those whose CD4 cell levels fail to rise above 200 despite long-term suppression of HIV through treatment have a more than doubled risk of death.
February 18, 2014
Genetically Engineered Antibodies Protect Mice From HIV
Engineering immune cells to produce “broadly neutralizing antibodies” protects mice with human immune systems against HIV infection.
February 14, 2014
HIV-Positive Youths Tend to Delay Entry Into Care
HIV-positive teens and young adults frequently do not enter medical care for HIV until relatively late in the course of the disease.
February 11, 2014
HIV Rates in Black MSM Are Linked to STIs, Economic Woes
New HIV infections in black men who have sex with men are linked to unemployment, lower socioeconomic status and other STIs.
HIV and Hepatitis C Transmission Routes Are Closely Linked
The apparent fact that transmission pathways for hepatitis C and HIV frequently converge may help better tailor prevention efforts.
Study Identifies How Blacks Fare in HIV ‘Treatment Cascade’
Less than half of all African Americans diagnosed with HIV have been prescribed antiretrovirals, and barely more than a third are virally suppressed.
February 10, 2014
Changes in Mood Affect Condom Use Among HIV-Positive Gay Men
HIV-positive gay men’s fluctuations in mood are linked to their sexual risk taking, according to a new study from Columbia University’s Mailman School of Public Health.
February 07, 2014
‘Individual Responsibility’ HIV Prevention Message May Backfire
The notion that preventing HIV transmission is a matter of “personal responsibility” may stifle important safer-sex negotiations among gays.
February 06, 2014
A Patient’s Race Affects How HIV Docs Discuss Adherence
HIV providers alter their communication methods based on the race of their patients and are more likely to discuss adherence with minorities than with whites.
February 05, 2014
FDA Approves Generic Reyataz for Use Abroad Via PEPFAR
The U.S. Food and Drug Administration has granted “tentative approval” to a generic formulation of Reyataz (atazanavir) to treat HIV abroad.
February 04, 2014
New Guidelines Get NYC Youths With HIV on ARVs Earlier
A 2009 shift in HIV treatment guidelines recommending earlier initiation preceded a drop in starting CD4 levels among New York City youths with the virus.

February 03, 2014
A Likely Uptick in PrEP Users as Studies Seek New Answers
Truvada as pre-exposure prophylaxis (PrEP) to prevent HIV has been slow to catch on, but the rate of new prescriptions appears to be accelerating.
More Treatment News

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ



Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dversescott
    Baltimore
    Maryland


    Newhopenate
    New Hope
    Pennsylvania


    jimmy807
    San Antonio
    Texas


    albsur7436
    San Francisco
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.